Report Detail
Global Hirudin Market Growth 2019-2024
- RnM2887074 |
- 06 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Other
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
According to the statistical data, Demand cannot be satisfied with supply. Currently, Hirudin market has a certain potential in USA, Europe and Asia Market. These areas demand are rapidly growth.
In recent years in China as the main ingredient to hirudin, there are many kinds of proprietary Chinese medicines, such as cerebral blood oral liquid, tablets thrombosis, blood capsule, with its annual output value of tens of millions. New drugs with leeches are constantly studied and introduced. Genetic engineering of recombinant leech-like peptide drugs to replace or hirudin as anticoagulant drug additives stasis, which can be achieved in the near future. As the injection for the treatment of cardiovascular diseases and cancer drugs, the need for further clinical research. Needless to say, recombinant hirudin-like peptide drug development will bring huge social and economic benefits.
According to this study, over the next five years the Hirudin market will register a 3.5% CAGR in terms of revenue, the global market size will reach US$ 4240 million by 2024, from US$ 3450 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hirudin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hirudin market by product type, application, key manufacturers and key regions and countries.
This study considers the Hirudin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Natural Hirudin
Recombinant Hirudin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thrombosis Disease
Tumor Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hirudin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hirudin market by identifying its various subsegments.
Focuses on the key global Hirudin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hirudin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hirudin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hirudin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hirudin Consumption 2014-2024
- 2.1.2 Hirudin Consumption CAGR by Region
- 2.2 Hirudin Segment by Type
- 2.2.1 Natural Hirudin
- 2.2.2 Recombinant Hirudin
- 2.3 Hirudin Consumption by Type
- 2.3.1 Global Hirudin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hirudin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hirudin Sale Price by Type (2014-2019)
- 2.4 Hirudin Segment by Application
- 2.4.1 Thrombosis Disease
- 2.4.2 Tumor Disease
- 2.4.3 Others
- 2.5 Hirudin Consumption by Application
- 2.5.1 Global Hirudin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hirudin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hirudin Sale Price by Application (2014-2019)
3 Global Hirudin by Players
- 3.1 Global Hirudin Sales Market Share by Players
- 3.1.1 Global Hirudin Sales by Players (2017-2019)
- 3.1.2 Global Hirudin Sales Market Share by Players (2017-2019)
- 3.2 Global Hirudin Revenue Market Share by Players
- 3.2.1 Global Hirudin Revenue by Players (2017-2019)
- 3.2.2 Global Hirudin Revenue Market Share by Players (2017-2019)
- 3.3 Global Hirudin Sale Price by Players
- 3.4 Global Hirudin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hirudin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hirudin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hirudin by Regions
- 4.1 Hirudin by Regions
- 4.1.1 Global Hirudin Consumption by Regions
- 4.1.2 Global Hirudin Value by Regions
- 4.2 Americas Hirudin Consumption Growth
- 4.3 APAC Hirudin Consumption Growth
- 4.4 Europe Hirudin Consumption Growth
- 4.5 Middle East & Africa Hirudin Consumption Growth
5 Americas
- 5.1 Americas Hirudin Consumption by Countries
- 5.1.1 Americas Hirudin Consumption by Countries (2014-2019)
- 5.1.2 Americas Hirudin Value by Countries (2014-2019)
- 5.2 Americas Hirudin Consumption by Type
- 5.3 Americas Hirudin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hirudin Consumption by Countries
- 6.1.1 APAC Hirudin Consumption by Countries (2014-2019)
- 6.1.2 APAC Hirudin Value by Countries (2014-2019)
- 6.2 APAC Hirudin Consumption by Type
- 6.3 APAC Hirudin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hirudin by Countries
- 7.1.1 Europe Hirudin Consumption by Countries (2014-2019)
- 7.1.2 Europe Hirudin Value by Countries (2014-2019)
- 7.2 Europe Hirudin Consumption by Type
- 7.3 Europe Hirudin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hirudin by Countries
- 8.1.1 Middle East & Africa Hirudin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hirudin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hirudin Consumption by Type
- 8.3 Middle East & Africa Hirudin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hirudin Distributors
- 10.3 Hirudin Customer
11 Global Hirudin Market Forecast
- 11.1 Global Hirudin Consumption Forecast (2019-2024)
- 11.2 Global Hirudin Forecast by Regions
- 11.2.1 Global Hirudin Forecast by Regions (2019-2024)
- 11.2.2 Global Hirudin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hirudin Forecast by Type
- 11.8 Global Hirudin Forecast by Application
12 Key Players Analysis
- 12.1 The Medicines Company
- 12.1.1 Company Details
- 12.1.2 Hirudin Product Offered
- 12.1.3 The Medicines Company Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 The Medicines Company News
- 12.2 Keyken
- 12.2.1 Company Details
- 12.2.2 Hirudin Product Offered
- 12.2.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Keyken News
- 12.3 Minapharm
- 12.3.1 Company Details
- 12.3.2 Hirudin Product Offered
- 12.3.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Minapharm News
- 12.4 Abbott
- 12.4.1 Company Details
- 12.4.2 Hirudin Product Offered
- 12.4.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Abbott News
- 12.5 SALUBRIS
- 12.5.1 Company Details
- 12.5.2 Hirudin Product Offered
- 12.5.3 SALUBRIS Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 SALUBRIS News
- 12.6 Pfizer, Inc
- 12.6.1 Company Details
- 12.6.2 Hirudin Product Offered
- 12.6.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Pfizer, Inc News
- 12.7 Teva Pharmaceutical Industries Ltd
- 12.7.1 Company Details
- 12.7.2 Hirudin Product Offered
- 12.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Teva Pharmaceutical Industries Ltd News
- 12.8 DUOPUTAI
- 12.8.1 Company Details
- 12.8.2 Hirudin Product Offered
- 12.8.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 DUOPUTAI News
- 12.9 Pentapharm
- 12.9.1 Company Details
- 12.9.2 Hirudin Product Offered
- 12.9.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Pentapharm News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hirudin . Industry analysis & Market Report on Hirudin is a syndicated market report, published as Global Hirudin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hirudin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
